VitrofluidiX

BiomimX

BiomimX develops organs-on-chip platforms that provide mechanical stimulation to 3D microtissues for drug and medical device testing by pharmaceutical and biotechnology companies.

Cellbox Labs

This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.

Hesperos

This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.

Intero Biosystems

The company develops human intestinal organoid platforms for pharmaceutical and biotechnology firms to replace animal testing in preclinical drug discovery and safety assessment.

MISO Chip

This company develops microfluidic tumor-on-a-chip platforms for biopharmaceutical firms and academic researchers to conduct preclinical ex vivo drug testing on human tissue models.

Finnadvance

This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.

NETRI

NETRI develops organ-on-chip devices and AI algorithms for pharmaceutical and cosmetic companies to predict drug toxicity and efficacy using human cell models.

MYLeukaemia

This company develops a bone-marrow-on-a-chip platform for functional precision oncology to test blood cancer drug efficacy for pharmaceutical companies and clinical researchers.